Skip to main navigation Skip to search Skip to main content

Immunoactinopathies revisited: understanding clinical manifestations and biological pathways

  • Fleur Hiensch
  • , Loïc Dupré
  • , Elisabeth Salzer*
  • *Corresponding author for this work
  • Leiden University
  • Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity)
  • Medical University of Vienna

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Immune cell functionality is highly dependent on the actin cytoskeleton. The actin cytoskeleton is regulated by a complex molecular machinery that involves multiple genes. Mutations in these genes can cause inborn errors of immunity, also termed immunoactinopathies, of which Wiskott-Aldrich syndrome is the best-characterized entity. Currently, mutations in 23 genes can be considered causative of immunoactinopathies. Immunoactinopathies are rare disease entities with complex combinations of clinical manifestations, including immunodeficiency, immune dysregulation, malignancies, atopy, thrombocytopenia and bleeding, skin involvement, or congenital defects. Prompt diagnosis is crucial, because hematopoietic stem cell transplantation in an early phase can offer cure and prevent further complications. This review provides a detailed summary of the clinical experience with immunoactinopathies so far, elaborates on the most distinguishing features of immunoactinopathies by providing a clinical categorization, and links this information to the underlying biological pathways. This information may be of help to clinicians in the diagnosis of patients and to eventually improve patient care.
Original languageEnglish
Pages (from-to)2709-2732
Number of pages24
JournalBlood
Volume145
Issue number23
DOIs
Publication statusPublished - 5 Jun 2025
Externally publishedYes

Fingerprint

Dive into the research topics of 'Immunoactinopathies revisited: understanding clinical manifestations and biological pathways'. Together they form a unique fingerprint.

Cite this